CRI, IMM go full throttle on R&D
Chembiotek Research International (CRI) and the associated Institute of Molecular Medicine (IMM) will be privately placing part of a proposed issue of $10 million fund with global pharmaceutical
Chembiotek Research International (CRI) and the associated Institute of Molecular Medicine (IMM) will be privately placing part of a proposed issue of $10 million fund with global pharmaceutical